Recovery of Resistant Alopecia Areata Treated with Tofacitinib: An 8-Year-Old Child's Case Report

Tofacitinib has been reported to activity in the recovery of alopecia areata (AA) in several reports, mainly from Western countries. We report the case of a young Indian boy with resistant AA who was treated with tofacitinib-based therapy. Improvements in terms of hair regrowth were observed within...

Descripción completa

Detalles Bibliográficos
Autor principal: Bhokare, Anil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9447467/
https://www.ncbi.nlm.nih.gov/pubmed/36081438
http://dx.doi.org/10.4103/ijt.ijt_15_22
_version_ 1784783861310291968
author Bhokare, Anil
author_facet Bhokare, Anil
author_sort Bhokare, Anil
collection PubMed
description Tofacitinib has been reported to activity in the recovery of alopecia areata (AA) in several reports, mainly from Western countries. We report the case of a young Indian boy with resistant AA who was treated with tofacitinib-based therapy. Improvements in terms of hair regrowth were observed within 6–8 weeks of treatment with oral tofacitinib 2.5 mg BID tablets, and the hair regrowth was nearly complete by 5 months. There were no associated side effects and the treatment with tofacitinib was well-tolerated.
format Online
Article
Text
id pubmed-9447467
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-94474672022-09-07 Recovery of Resistant Alopecia Areata Treated with Tofacitinib: An 8-Year-Old Child's Case Report Bhokare, Anil Int J Trichology Case Report Tofacitinib has been reported to activity in the recovery of alopecia areata (AA) in several reports, mainly from Western countries. We report the case of a young Indian boy with resistant AA who was treated with tofacitinib-based therapy. Improvements in terms of hair regrowth were observed within 6–8 weeks of treatment with oral tofacitinib 2.5 mg BID tablets, and the hair regrowth was nearly complete by 5 months. There were no associated side effects and the treatment with tofacitinib was well-tolerated. Wolters Kluwer - Medknow 2022 2022-07-16 /pmc/articles/PMC9447467/ /pubmed/36081438 http://dx.doi.org/10.4103/ijt.ijt_15_22 Text en Copyright: © 2022 International Journal of Trichology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Case Report
Bhokare, Anil
Recovery of Resistant Alopecia Areata Treated with Tofacitinib: An 8-Year-Old Child's Case Report
title Recovery of Resistant Alopecia Areata Treated with Tofacitinib: An 8-Year-Old Child's Case Report
title_full Recovery of Resistant Alopecia Areata Treated with Tofacitinib: An 8-Year-Old Child's Case Report
title_fullStr Recovery of Resistant Alopecia Areata Treated with Tofacitinib: An 8-Year-Old Child's Case Report
title_full_unstemmed Recovery of Resistant Alopecia Areata Treated with Tofacitinib: An 8-Year-Old Child's Case Report
title_short Recovery of Resistant Alopecia Areata Treated with Tofacitinib: An 8-Year-Old Child's Case Report
title_sort recovery of resistant alopecia areata treated with tofacitinib: an 8-year-old child's case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9447467/
https://www.ncbi.nlm.nih.gov/pubmed/36081438
http://dx.doi.org/10.4103/ijt.ijt_15_22
work_keys_str_mv AT bhokareanil recoveryofresistantalopeciaareatatreatedwithtofacitiniban8yearoldchildscasereport

Ejemplares similares